Absence of a morning peak in ventricular tachycardia and fibrillation events in nonischemic heart disease: Analysis of therapies by implantable cardioverter defibrillators

PACE - Pacing and Clinical Electrophysiology

Volumn 24, Issue 11, 2001, Pages 1602-1606

  Taneda, K ^a   Aizawa, Y ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Circadian variability; Implantable cardioverter defibrillator; Ischemic heart disease; Ventricular fibrillation; Ventricular tachycardia; adrenergic blocker

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; METOPROLOL; PROPRANOLOL;

ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CIRCADIAN RHYTHM; DEFIBRILLATOR; DRUG EFFECT; FEMALE; HEART DISEASE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; ISCHEMIC HEART DISEASE; JAPAN; MAJOR CLINICAL STUDY; MALE; RECURRENT DISEASE;

EID: 0035161059     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2001.01602.x     Document Type: Article

References (23)

1. Ventricular tachycardia initiated by high energy cardioversion in a patient with an implantable cardioverter defibrillator
2. Increased morning incidence of myocardial infarction in the ISAM Study: Absence with prior beta-adrenergic blockade
3. Time of onset of symptoms of acute myocardial infarction
4. Temporal patterns of stroke onset
5. Circadian variation in the frequency of sudden cardiac death
6. Morning peak in ventricular tachyarrhythmias detected by time of implantable cardioverter-defibrillator therapy
7. Circadian variation of ventricular arrhythmia recurrences after cardioverter-defibrillator implantation in patients with healed myocardial infarcts
8. Circadian variation of sustained ventricular tachyarrhythmias terminated by appropriate shocks in patients with an implantable cardioverter defibrillator
9. Incidence and mechanism of interruption of reentrant ventricular tachycardia with rapid pacing
10. Electrophysiologic findings in idiopathic recurrent ventricular fibrillation: Special reference to mode of induction, drug testing, and long-term outcomes
11. The Antiarrhythmics versus Implantable Defibrillator (AVID) Investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillator in patients resuscitated from near-fatal ventricular arrhythmias
12. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmias
13. ACC/AHA Guideline for implantation of cardiac pacemakers and antiarrhythmia devices. A report of ACC/AHA Task force on practice guidelines (committee on pacemaker implantation)
14. Timing of sudden death in patients with heart failure
15. Effects of left ventricular dysfunction on the circadian variation of ventricular premature complexes in healed myocardial infarction
16. Differing circadian patterns of symptom onset in subgroups of patients with acute myocardial infarction
17. Propranolol the morning increase in sudden cardiac death (The Beta-Blocker Heart Attack Trial Experience)
18. Circadian variation in the frequency of onset of acute myocardial infarction
19. Modifiers of timing and possible triggers of acute myocardial infarction in thrombolysis in myocardial infarction phase II (TIMI II) study group
20. Increased morning incidence of myocardial infarction in the ISAM study: Absence with prior beta-adrenergic blockade
21. The cardiac insufficiency bisoprolol study II(CIBIS-II) a randomized trial
22. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized Intervention trial in congestive heart failure (MERIT-HF)
23. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugadas' syndrome